Accelerant (ARX) is One of the Best Insurance Stocks to Invest in, Here is Why

Accelerant Holdings (NYSE:ARX) is one of the 11 best insurance stocks to buy right now.

Back on February 23, Paul Newsome from Piper Sandler reduced the price target on Accelerant Holdings (NYSE:ARX) from $18 to $13. The analyst maintained an Overweight rating on the stock, which currently yields almost 17% upside potential despite the downward revision.

austin-distel-jpHw8ndwJ_Q-unsplash

On February 17, Raymond James analyst C. Gregory Peters reduced the price target on Accelerant Holdings (NYSE:ARX) to $13 from $21 while maintaining an Outperform rating. The fear of replacement by AI has led to a decline of around 22% so far this year for insurance brokers and insurance technology stocks.

Yet the analyst observed that stable credit spreads, interest rates, and management guidance suggest that there has been no underlying deterioration in fundamentals. Although multi-year investments in AI infrastructure and significant hyperscale capital expenditures support premium growth, organic growth and margin expansion may slow in 2026. Large-cap brokers are still well-positioned to outperform the market and could accelerate share repurchases if valuations remain compressed.

Accelerant Holdings (NYSE:ARX) is a data-led risk exchange that brings together specialty insurance underwriters and risk capital partners. It offers a platform to facilitate members and risk capital partners. The company also delivers underwriting services for insurance and reinsurance policies.

While we acknowledge the risk and potential of ARX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ARX and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.